hotspot -WSS

hotspot

author：knowledge 2025-08-30 19:12:01 - browse：9778

he exterior of the U.S. Capitol building is seen at sunrise — Sarah Silbiger/Getty Images

WASHINGTON — Panels in both the House and Senate have now passed restrictions to drug middlemen business practices, increasing the chances of those measures being included in future government spending bills.

The bipartisan reforms to pharmacy benefit managers were among 21 bills that the House Energy & Commerce health subcommittee passed today. The policies are not identical, but at least three PBM reforms have been passed by panels in both chambers:

One that would replace PBM fees that are tied to a percentage of drug prices with flat fees
Another that would require Medicare to create standard performance measures on which PBMs base pharmacy payments
A third that would require PBMs to report a host of information, including drug costs, savings, beneficiary out-of-pocket costs, payments to pharmacies, and the amount of business directed to PBM-owned pharmacies

The Energy & Commerce subcommittee also passed other bills that mirror legislation that Senate Finance also has passed. That includes legislation to ensure seniors pay no more for drugs than insurers, and a measure that lets insurers add less-expensive biosimilars to formularies mid-year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Physician executives need more than on

entertainment

WSS

VC firm General Catalyst wants to buy a health system

Oprah kicked off a national conversation on obesity. Let's have it

3 questions for the future of Biden's cancer moonshot

There's no autism epidemic. It's an autism diagnosis epidemic

Senate panel eyes new effort on drug shortages

A Q&A with the global head of Boehringer Ingelheim's innovation unit

focus

hotspot

entertainment

Drug repurposing or repositioning? The language matters

FDA panel signals lack of confidence in Amgen cancer drug data

Walensky prepares to leave CDC — and Congress — behind

Donor acceptance rates hint at racial, gender bias in heart transplants: study

State Dept. review finds Biden bears some blame for Afghanistan failures

Food as medicine: Medically tailored meals may get standardized

Tori Bowie and the unacceptable rates of Black maternal death

Study says nonprofit hospitals fall short in charity care spending

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Wikipedia

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Steward Health Care has deal to sell doctor network to UnitedHealth

Study says nonprofit hospitals fall short in charity care spending

Why the world’s most expensive drug might be worth the price

Abortion pill case raises question: who can sue the FDA?

Chan Zuckerberg Biohub Chicago to focus on inflammation

hotspot

leisure time

entertainment

focus